Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04907136 · ClinicalTrials.gov registry record · NA

Developing and Testing Health Warning Labels on the ENDS Device

A NA study of Electronic Cigarette Use, sponsored by Florida International University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04907136 is a NA study of Electronic Cigarette Use that is actively recruiting participants, run by Florida International University. The registered enrollment target is 80 participants, below the 207-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04907136, a NA study of Electronic Cigarette Use, is actively recruiting participants, sponsored by Florida International University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.

Conditions Studied

Interventions

  • OTHER Preferred ENDS
  • OTHER Preferred ENDS with HWL

Study Locations (1)

Florida

  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-12-13
Est. Completion 2027-04-30
Phase NA

Sponsor

Florida International University

89 total trials

What the Registry Record Tells You About NCT04907136

The ClinicalTrials.gov registry entry for NCT04907136 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (61% lower). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which Preferred ENDS is the first listed.

NCT04907136 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04907136 about?

NCT04907136 is a clinical study titled "Developing and Testing Health Warning Labels on the ENDS Device". In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm ...

What is the current status of trial NCT04907136?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-12-13. Estimated completion is 2027-04-30.

What conditions does trial NCT04907136 study?

This clinical trial studies the following conditions: Electronic Cigarette Use.

What interventions are being tested in trial NCT04907136?

The interventions under investigation include: Preferred ENDS (OTHER), Preferred ENDS with HWL (OTHER).

Who is sponsoring clinical trial NCT04907136?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04907136 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Electronic Cigarette Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.